VSG Whistleblower Lawyers in the News 2011-2013
Since the founding of Vogel, Slade & Goldstein, LLP, each of its principals has been sought out by major news outlets, law schools, legal organizations and the US Congress to provide insight and information about qui tam law and lawsuits. The following are examples of events, organizations and media stories in which they participated:
Janet Goldstein spoke on the False Claims Act at the Health Care Compliance Association’s 17th Annual Compliance Institute. The 5-day conference was held in Washington, D.C., beginning April 21, 2013. The 3-hour panel entitled False Claims Act Developments covered a variety of topics including qui tam and retaliation actions, and relators’ rewards. April 21, 2013.
Rob Vogel co-chaired a CLE conference on qui tam cases and the False Claims Act, at the Hotel Nikko in San Francisco on April 18-19, 2013. The conference featured panelists from U.S. Attorney’s Offices, State Attorney General’s Offices, JAMS, Stanford Law School, and leading law firms across the United States. April 18-19, 2013.
Shelley Slade taught a class at Cornell Law School on the “first-to-file” provision in the federal False Claims Act. Launched by the Dean of Cornell Law School in conjunction with a practicing qui tam attorney, the course utilizes the first-ever, major law school syllabus dedicated exclusively to the False Claims Act and relies on regular guest speakers from the government, defense bar and qui tam bar. February 18, 2013.
Robert Vogel, co-chair of the Procurement Fraud Committee of the ABA Section of Public Contract Law, moderated a panel discussion in Washington, DC. The topic was recent court decisions in False Claims Act cases brought by qui tam whistleblowers. The panelists included Michael Granston, Acting Director of the Commercial Fraud Section, Civil Division, U.S. Department of Justice. October 18, 2012.
Janet Goldstein was reappointed as a national co-chair of the Qui Tam Subcommittee of the American Bar Association, Criminal Justice Section, for a two year term. September 24, 2012.
Shelley Slade was a panelist on a “False Claims Act 101” Panel at the Taxpayers Against Fraud Education Fund 12th Annual Conference in Washington, D.C. The panel trained new qui tam attorneys on the basics of False Claims Act jurisprudence and practice. September 12, 2012.
Robert Vogel participated on the panel “The False Claims Act-Broadening the Use of the False Claims Act to Address Perceived Procurement Waste, Abuse and Fraud” at the Practicing Law Institute, Government Contracts 2012 (Washington, DC). September 20, 2012.
Shelley Slade participated on the panel “The Rise of Qui Tam Litigation and its Impact on How Fraud Cases are Investigated and Prosecuted” at the Edward Bennett Williams’ American Inns of Court Meeting (Washington, D.C.). Her co-panelists included Joyce Branda, Acting Deputy Assistant Attorney General, U.S. Department of Justice; Gary Giampetruzzi, Assistant General Counsel & Chief of Government Investigations, Pfizer; and, Brien O’Connor, Partner, Ropes & Gray. September 20, 2012.
Shelley Slade was quoted in an article entitled “GSK Ills Symptomatic of Wider Malaise” in the Financial Times, on the topic of how best to deter off-label sales pitches, kickbacks and other marketing misconduct by pharmaceutical companies. Ms. Slade argued that only criminal action against the individual executives who set these schemes in motion will bring lasting reform. July 6, 2012.
Robert Vogel participated in a panel discussion of “Settlements of Government Procurement Cases” at the ABA National Institute on the Civil False Claims Act and Qui Tam Enforcement in Washington, DC. June 8, 2012.
Janet Goldstein moderated a panel discussion on “Litigating False Claims Act Cases” and co-led the “Qui Tam Attorneys Workshop” at the ABA National Institute on Health Care Fraud in Las Vegas, NV. May 9-11, 2012.
Robert Vogel, co-chair of the Procurement Fraud Committee of the ABA Public Contract Law Section, moderated a panel on “Negotiating Settlements in Procurement Fraud Cases” in Washington, DC. Included in the panel were Brian Miller, Inspector General of the General Services Administration, and Judith Rabinowitz, an Assistant Director of the Civil Frauds Section of the U.S. Department of Justice. May 9, 2012.
Shelley Slade was quoted in an article in the Wall Street Journal on settlement negotiations to resolve allegations that Johnson & Johnson unlawfully marketed the antipsychotic drug Risperdal. March 13, 2012.
Robert Vogel participated in a panel discussion of “Implied Certification under the False Claims Act” at the ABA Federal Procurement Institute in Annapolis, MD. March 22-23, 2012.
Shelley Slade, as a member of the Board and Executive Committee of the non-profit Taxpayers Against Fraud, presented the Honest Abe Integrity in Government award to Michael F. Hertz, who, at the time, was the Deputy Assistant Attorney General for the Civil Division of the U.S. Department of Justice. In her remarks, Ms. Slade noted that Mr. Hertz has steered the government’s enforcement of the FCA with exceptional integrity, fairness, brilliance and fearlessness for 30 years. Mr. Hertz sadly passed away in April 2012. September 13, 2011.